Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: Mechanisms and efficacies

M. Yazdani Abyaneh, R. D. Griffith, L. Falto-Aizpurua, K. Nouri

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Vitiligo is a disorder of pigmentation affecting about 1% of the global population. It is a psychologically devastating disease with suboptimal treatment options. Narrowband ultraviolet B (NB-UVB) phototherapy has become a first-line choice for treating generalized disease. In recent years, topical calcineurin inhibitors, vitamin D analogues, antioxidant agents and other therapies have been combined with NB-UVB to improve its efficacy. This article will address what is known about the mechanisms of action of these treatments and how they may complement NB-UVB on a cellular level, as well as offer a comprehensive, evidence-based review of clinical outcomes with combination therapies.

Original languageEnglish (US)
Pages (from-to)1610-1622
Number of pages13
JournalJournal of the European Academy of Dermatology and Venereology
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2014

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: Mechanisms and efficacies'. Together they form a unique fingerprint.

  • Cite this